Results 81 to 90 of about 66,971 (207)
Fluoroquinolone use restrictions in patients with uncomplicated infections and safety issues [PDF]
Клиническая микробиология и антимикробная химиотерапия, 2017 n May 2016, US FDA advised to restrict fluoroquinolones use in patients with acute sinusitis, acute exacerbations of chronic bronchitis, and uncomplicated urinary tract infections.
Ushkalova E.A., Zyryanov S.K.
doaj
Antibiotics, 2019 The Food and Drug Administration (FDA) safety review revealed that the use of fluoroquinolones (FQs) is linked with disabling and potentially permanent serious adverse effects.
Benitta Mathews +5 more
doaj +1 more source
The association between oral fluoroquinolones and incident seizure event
, 2014 BACKGROUND: Fluoroquinolones are a class of antibiotics prescribed for various infections. Several case reports have indicated the potential association between the use of oral fluoroquinolones and the development of incident seizure event.
Chan, EW, Chui, SLC, Wong, ICK
core +1 more source
Fluoroquinolones for treating tuberculosis (presumed drug-sensitive). [PDF]
, 2013 Currently the World Health Organization only recommend fluoroquinolones for people with presumed drug-sensitive tuberculosis (TB) who cannot take standard first-line drugs.
Ziganshina L., Titarenko A., Davies G.
core
Fluoroquinolones for treating tuberculosis
, 2008 Background: Fluoroquinolones are sometimes used to treat multiple-drug-resistant and drug-sensitive tuberculosis. The effects of fluoroquinolones in tuberculosis regimens need to be assessed.
Ziganshina, Lilia E., Squire, Bertie
core +1 more source
Fluoroquinolones inhibit HCV by targeting its helicase
, 2012 Background: HCV has infected \u3e170 million individuals worldwide. Effective therapy against HCV is still lacking and there is a need to develop potent drugs against the virus.
Ali, Syed H. +4 more
core
The New Fluoroquinolones: A Critical Review
, 2016 OBJECTIVE: This paper reviews the literature available on the new fluoroquinolones – clinafloxacin, gatifloxacin, grepafloxacin, levofloxacin, moxifloxacin, sparfloxacin and trovafloxacin – to compare these agents with each other and contrast them with ...
Karlowsky, James A +6 more
core +1 more source
Topical fluoroquinolones for eye and ear
, 2007 Topical fluoroquinolones are now available for use in the eye and ear. Their broad spectrum of activity includes the common eye and ear pathogens Staphylococcus aureus and Pseudomonas aeruginosa.
Berke, Ethan M., Morden, Nancy E.
core
Infection and Drug Resistance, 2018 Mohamed Abdo Rizk,1,2 Mahmoud AbouLaila,3 Shimaa Abd El-Salam El-Sayed,1,4 Azirwan Guswanto,1,5 Naoaki Yokoyama,1 Ikuo Igarashi1 1National Research Center for Protozoan Diseases, Obihiro University of Agriculture and Veterinary Medicine, Inada‑Cho ...
Rizk MA +5 more
doaj
Fluoroquinolones for Treating Tuberculosis
, 2017 Tuberculosis (TB) remains a significant global health and socioeconomic challenge. The duration of current anti-TB therapies, the adverse effects of certain anti-TB drugs and the growing problem of drug-resistant TB on an international scale mean that it
McHugh, TD, Lipman, MCI, Kumar, K
core